Brief: India's Zim Laboratories June-Qtr Consol Pat Rises
26/07/2022 13:51
July 26 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* JUNE-QUARTER CONSOL PAT 51.5 MILLION RUPEES VERSUS PROFIT
1.9
MILLION RUPEES YEAR AGO
* JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 927.5 MILLION
RUPEES
VERSUS 641.7 MILLION RUPEES YEAR AGO
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia